Page 17 - Ali Chartan News Today : Breaking News, Live Updat

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

Published: April 18, 2022

New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, will provide...

Source: asiaone.com

Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Published: April 13, 2022

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Source: prnewswire.com

Novavax and Serum Institute of India Receive Emergency Use Authorization

Published: April 11, 2022

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next

Source: ryt9.com

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand

Published: April 8, 2022

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Source: prnewswire.com

Novavax, Inc.: Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)

Published: March 31, 2022

If granted, Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17 years in EuropeGAITHERSBURG, Md., March 31, 2022 /PRNewswire/

Source: finanznachrichten.de

Page 17 - Ali Chartan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Top News In Ali Chartan Today - Breaking & Trending Today

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Novavax and Serum Institute of India Receive Emergency Use Authorization

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand

Novavax, Inc.: Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)